Trial Profile
Magnetoencephalographic Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Apr 2010
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary) ; Zolpidem
- Indications Insomnia
- Focus Pharmacodynamics
- 02 Apr 2010 Actual number of patients added to 24 as reported by ClinicalTrials.gov.
- 02 Apr 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 02 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.